Niederer Kraft Frey has advised SpineArt, one of the fastest growing spine companies, on its CHF 20 million convertible financing. The funding follows the completion of enrollment in the two Baguera® C IDE studies, underlining SpineArt’
Nestlé Capital Corporation has successfully completed its issuance of USD 600 m 4.650% Notes due 2029, USD 450 m 4.750% Notes due 2031, USD 800 m 4.875% Notes due 2034, and USD 650 m 5.100% Notes due 2054. The Notes are guaranteed by the Nestlé group’s
Enthus Group GmbH, a German IT solution provider with operations in Germany, Austria and Switzerland, has acquired Global IT group, another IT solution provider based in Neerach, Switzerland. With the acquisition, Enthus will significantly expand
Baker McKenzie has advised the seller on the sale of a majority stake in Stars in Town to the Gadget Group. Stars in Town operates a music festival in Schaffhausen. The traditional festival has been
Roche Holdings has successfully completed its issuance of USD 3.875 bn in aggregate principal amount of senior notes, consisting of USD 875 m 4.790% Notes due 2029, USD 750 m 4.909% Notes due 2031, USD 1.25 bn 4.985% Notes due 2034, and USD 1 bn 5.218% Notes
Galderma Group AG , the pure-play dermatology category leader, has announced the launch of its Initial Public Offering on the SIX Swiss Exchange. According to various market sources and reports, the Skincare business is looking to
Niederer Kraft Frey has advised Mandi Ventures on its investment in Cultivated Biosciences SA. Mandi is an early-stage venture capital fund, focused on accelerating the adoption of disruptive technologies in the food and agriculture industries.
The American supplier of analytical instruments, Thermo Fisher Scientific, with annual revenues of close to US$50 billion, has successfully completed the issuance of its inaugural Swiss franc bonds. It is reportedly the largest foreign Swiss
Baker McKenzie Switzerland has advised Commerzbank Aktiengesellschaft, Zurich branch, on guarantee facility agreements for Calik Enerji Swiss AG, totaling USD 586.25 million. This included a guarantee agreement covered by Swiss Export Risk Insurance (SERV). Guaranteed by
Abrantix and B2 Payment Solutions have combined their expertise and knowledge to found the joint venture company PaytestLab AG. This represents a strategic move to revolutionise the field of automated payment software testing by combining
